Patents by Inventor Rifang LUO

Rifang LUO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11844880
    Abstract: A recombinant human collagen-based multifunctional stent coating and a preparation method thereof are provided. The preparation method includes (1) activating a substrate material; (2) placing the activated substrate material in an amino compound-containing solution for a reaction to obtain an aminated substrate material; (3) placing the aminated substrate material in a polyanion electrolyte solution for a reaction, and cleaning with deionized water. The recombinant human collagen-based multifunctional stent coating prepared by the present invention effectively improves the anticoagulation and rapid endothelialization performance of biomaterials, such as vascular stent materials, and reduces the late thrombosis and restenosis problems existing in current stent materials.
    Type: Grant
    Filed: May 26, 2021
    Date of Patent: December 19, 2023
    Assignees: Sichuan University, Shanxi Jinbo Bio-Pharmaceutical Co., Ltd
    Inventors: Yunbing Wang, Li Yang, Rifang Luo, Lu Lu, Xia Yang, Xingdong Zhang
  • Publication number: 20230347016
    Abstract: The present invention provides a valve material having a long-acting antithrombosis property and a preparation method therefor. The preparation method therefor comprises the following steps: performing glutaraldehyde cross-linking treatment on an animal-derived biological valve material, so that the valve material can resist decomposition for a long time; soaking the treated valve material in a formulation solution containing a cross-linking agent and a modifier for 10-60 min, then increasing the temperature to 30-60° C., and performing heat treatment for 1-12 h; and rinsing the valve material after heat treatment, so as to obtain the valve material. The valve material prepared by the method has excellent antithrombosis and anti-calcification properties, and can effectively solve the problem of calcification and thrombosis in the valve material treated by existing means of glutaraldehyde cross-linking.
    Type: Application
    Filed: June 15, 2021
    Publication date: November 2, 2023
    Applicant: VENUS MEDTECH (HANGZHOU) INC.
    Inventors: Yunbing WANG, Rifang LUO, Li YANG, Fanjun ZHANG
  • Publication number: 20230330299
    Abstract: A long-acting super-hydrophobic anticoagulant biological valve and a preparation method therefor. The preparation method includes the following steps: (1) treating a biological valve material with glutaraldehyde; (2) placing the biological valve material treated in step (1) into an acid liquid containing a polyphenol compound and metal ions, and adding an oxidant for reaction; and (3) reacting the biological valve material treated in step (2) with a hydrophobic substance. According to the method, a super-hydrophobic coating having a long-acting high water contact angle and a low rolling angle is prepared on the surface of the biological valve by means of a simple and stable operation process without affecting the performance of the valve body, and the requirements of long-acting anticoagulation are met by resisting the adsorption of plasma proteins.
    Type: Application
    Filed: June 18, 2023
    Publication date: October 19, 2023
    Applicant: JILIN VENUS HAOYUE MEDICAL LIMITED
    Inventors: Li Yang, Yunbing Wang, Rifang Luo
  • Publication number: 20230218803
    Abstract: The present invention provides a valve material having synergistic anti-coagulation and anti-calcification functions and a preparation method therefor. The preparation method comprises the following steps: performing glutaraldehyde cross-linking treatment on an animal-derived biological valve material; immersing the treated valve material in a blocking solution containing an amine compound for 0.5-6 h, thereby blocking the remaining aldehyde groups after glutaraldehyde cross-linking; then placing the valve material into a reaction solution containing an anticoagulant and a cross-linking agent, and performing cross-linking treatment for 6-24 h at 4° C.-37° C.; and finally washing and obtaining the valve material, and storing the valve material in a mixed solvent of glutaraldehyde or isopropyl alcohol/glycerol. The method can effectively solve the problem of calcification and thrombosis caused by residual aldehyde groups in a valve material prepared by the existing method.
    Type: Application
    Filed: June 15, 2021
    Publication date: July 13, 2023
    Applicant: JILIN VENUS HAOYUE MEDICAL LIMITED
    Inventors: Yunbing WANG, Li YANG, Rifang Luo, Linhua LI
  • Publication number: 20210369923
    Abstract: A recombinant human collagen-based multifunctional stent coating and a preparation method thereof are provided. The preparation method includes (1) activating a substrate material; (2) placing the activated substrate material in an amino compound-containing solution for a reaction to obtain an aminated substrate material; (3) placing the aminated substrate material in a polyanion electrolyte solution for a reaction, and cleaning with deionized water. The recombinant human collagen-based multifunctional stent coating prepared by the present invention effectively improves the anticoagulation and rapid endothelialization performance of biomaterials, such as vascular stent materials, and reduces the late thrombosis and restenosis problems existing in current stent materials.
    Type: Application
    Filed: May 26, 2021
    Publication date: December 2, 2021
    Applicants: Sichuan University, Shanxi Jinbo Bio-Pharmaceutical Co., Ltd
    Inventors: Yunbing WANG, Li YANG, Rifang LUO, Lu LU, Xia YANG, Xingdong ZHANG
  • Publication number: 20210322641
    Abstract: An anti-thrombotic and endothelialization-enhanced bioprosthetic valve material and preparation thereof are provided. The preparation method includes the following steps: immersing a glutaraldehyde cross-linked bioprosthetic valve material in functional reagent solution for 1-24 h, adjusting pH value of the solution to 3-8, removing it from solution and cleaning with deionized water. The new valve material of the present invention can effectively reduce the toxicity and side effects of the existing glutaraldehyde cross-linked bioprosthetic valve material and effectively reduce thrombosis, along with enhanced endothelialization. The material prepared can be used for pulmonary valve, aortic valve, mitral valve, tricuspid valve, venous valve and other cardiovascular implantable medical devices.
    Type: Application
    Filed: April 21, 2021
    Publication date: October 21, 2021
    Applicant: Sichuan University
    Inventors: Li YANG, Yunbing WANG, Rifang LUO, Xingdong ZHANG